Atlas Trials

The Value of Molecular Residual Disease Monitoring Based on ctDNA in Resected Pancreatic Cancer

Clinical trial NCT05802407 · RECRUITING

Trial details

NCT number
NCT05802407
Sponsor
Peking Union Medical College Hospital
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Pancreatic CancerResectable Carcinoma
Start date
2023-02-01
Primary completion
2026-02-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.